Table 1 Final cohort demographics

From: Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination

Group

Bivalent Recipients

Bivalent Non-recipients

# Participants

30

10

# Female (%)

21 (70%)

6 (60%)

# Male (%)

9 (30%)

4 (40%)

Mean age (range)

52.2 (26–74)

50.8 (35–71)

Mean days between serum collection (range)

22.1 (14–38)

20 (14–41)

Mean interval since prior vaccination (range)

361.2 (154–405)

706.9 (555–742)

Prior vaccine type

bivalent Wuhan-Hu-1/BA.4-5

monovalent Wuhan-Hu-1

Mean # of prior infections (range)

0.8 (0–3)

0.9 (0–2)

Median # of prior infections (range)

1 (0–3)

1 (0–2)

  1. # denotes the number of participants that fit indicated characteristics or prior infection events.